AllDayGLP
70mg (BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg)
ALG-B2024-003
≥98%
GLOW Stack Research Blend 70mg
$199.99
Batch: ALG-B2024-003
Store lyophilized powder at -20°C. After reconstitution, refrigerate at 2-8°C and use within 30 days. Reconstitute each peptide separately.
Pre-blended 3-peptide research compound combining BPC-157, GHK-Cu, and TB-500 for tissue repair and skin regeneration studies.
For research or professional use only, where legally permitted. Not intended to diagnose, treat, cure, or prevent any disease.
The GLOW Stack is a comprehensive pre-blended research formulation combining three well-characterized peptides — BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg) — into a single 70mg lyophilized preparation. This triple-peptide blend is designed for laboratory investigation of synergistic tissue repair, extracellular matrix remodeling, and dermal regeneration pathways. **GHK-Cu (50mg)** functions as the primary matrix remodeler in this stack. This copper-binding tripeptide stimulates the synthesis of collagen types I, III, and V, activates matrix metalloproteinases (MMPs) for controlled extracellular matrix turnover, and exhibits antioxidant properties by chelating free copper ions that would otherwise catalyze oxidative damage. GHK-Cu also acts as a chemoattractant, recruiting macrophages and other immune cells to sites of tissue investigation. **BPC-157 (10mg)** — a synthetic pentadecapeptide derived from a protective gastric juice protein — serves as the local repair agent. Its documented mechanisms include upregulation of vascular endothelial growth factor (VEGF) for angiogenesis, modulation of nitric oxide (NO) synthesis, and promotion of growth factor expression. These actions collectively support granulation tissue formation and fibroblast activity in research models of wound healing. **TB-500 (10mg)** — the synthetic thymosin beta-4 derivative — provides systemic tissue remodeling support through actin regulation. By sequestering G-actin monomers, TB-500 promotes endothelial and epithelial cell migration essential for angiogenesis and re-epithelialization. Its anti-inflammatory properties and tissue remodeling capabilities complement the local actions of BPC-157 and the matrix-directed effects of GHK-Cu. This pre-blended research formulation is intended for laboratory investigation of peptide synergy in tissue repair, wound healing models, dermal regeneration studies, and extracellular matrix research. Not for human or veterinary use. Each peptide should be reconstituted separately and can be combined in the same injection session using separate syringes for research administration studies.